# REGENXBIO Inc. (RGNX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RGNX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 6.39M | $ -90.05M | $ -77.42M | $ 71.07M | $ 21.08M |
| 2025 | $ 174.52M | $ -198.51M | $ -129.40M | $ 260.52M | $ 102.73M |
| 2024 | $ 87.58M | $ -238.70M | $ -184.53M | $ 82.03M | $ 259.65M |
| 2023 | $ 97.57M | $ -284.90M | $ -246.92M | $ 89.29M | $ 311.74M |
| 2022 | $ 125.92M | $ -313.15M | $ -266.11M | $ 94.80M | $ 516.20M |
| 2021 | $ 559.08M | $ 151.96M | $ 149.34M | $ 86.68M | $ 764.30M |
| 2020 | $ 196.91M | $ -141.72M | $ -103.10M | $ 72.65M | $ 377.75M |
| 2019 | $ 45.48M | $ -122.28M | $ -154.15M | $ 11.30M | $ 450.20M |
| 2018 | $ 288.58M | $ 131.99M | $ 120.67M | $ 5.85M | $ 508.85M |
| 2017 | $ 14.00M | $ -98.57M | $ -87.77M | $ 0 | $ 183.03M |
| 2016 | $ 6.31M | $ -86.63M | $ -78.02M | $ 0 | $ 161.74M |
| 2015 | $ 10.65M | $ -32.03M | $ -32.34M | $ 0 | $ 216.81M |
| 2014 | $ 8.64M | $ -6.32M | $ -3.39M | $ 2.40M | $ -5.70M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 3.37 |
| Liabilities / Eq | 15.22 |
| Current Ratio | 2.62 |

## Other views

- [Metrics](https://sponda.capital/en/RGNX.md)
- [Charts](https://sponda.capital/en/RGNX/charts.md)
- [Compare](https://sponda.capital/en/RGNX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.